FIRST EXTENSION - GRANTED
granted
on 30 Sep 2024
Last Applicant/ Owned by
210 West 7th Street
Austin
TX
78701
Serial Number
97331598 filed on 25th Mar 2022
Registration Number
N/A
Correspondent Address
Robin Lightner Maisashvili
Filing Basis
1. intent to use
2. intent to use current
3. filed as use application
4. use application currently
Disclaimer
NO DATA
JAMES P. ALLISON INSTITUTE
(Based on Use in Commerce) Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, the Read More
Classification Information
Class [045]
Personal & Legal & Social Services
(Based on Intent to Use) Providing patient advocate services in the treatment of diseases and disorders utilizing immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [044]
Medical, Beauty & Agricultural Services
(Based on Intent to Use) Medical services; Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Medical services relating to cancer; Dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
(Based on Use in Commerce) Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer
First Use Date in General
24th Mar 2022
First Use Date in Commerce
24th Mar 2022
Class [041]
Education and Entertainment Services
(Based on Intent to Use) Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; arranging and conducting of training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [036]
Insurance & Financial Services
(Based on Use in Commerce) Charitable fundraising services
First Use Date in General
24th Mar 2022
First Use Date in Commerce
24th Mar 2022
Class [035]
Advertising, Business & Retail Services
(Based on Intent to Use) Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97331598
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Sep 2024 | SOU EXTENSION 1 GRANTED |
| 30th Sep 2024 | SOU EXTENSION 1 FILED |
| 30th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Sep 2024 | SOU TEAS EXTENSION RECEIVED |
| 02th Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 06th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 06th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |